Zentalis : Zentalis Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing small molecule therapeutics targeting fundamental biological pathways of cancers. The Company is developing a broad pipeline of potentially best-in-class oncology candidates, including ZN-c5, an oral selective estrogen receptor degrader for ER+/HER2- breast cancer, ZN-c3, a WEE1 inhibitor, ZN-d5, a BCL-2 inhibitor and ZN-e4, an EGFR inhibitor. Zentalis has operations in both New York and San Diego.
Sector/Industry:
Healthcare/Biotechnology
Characteristics:
Based in...
US - Middle Atlantic
Disease Space
Oncology
Listing
Public, USA
Market Cap
1B +
Website:
Profiles:
Address:
530 Seventh Avenue, Ste 2201
Corner of 39 St
New York, NY 10018
United States

Company Participants at Zentalis Virtual KOL Event focus on WEE1 Inhibitor

  • Anthony Sun, CEO

Lead Programs

ZN-c5: Oral SERD

oral selective estrogen receptor degrader (SERD)

Indication Phase
Breast Cancer 1/2

ZN-c3: WEE1

oral inhibitor of WEE1

Indication Phase
Solid Tumors 1/2

ZN-d5: BCL-2

oral selective inhibitor of B-cell lymphoma 2 (BCL-2)

Indication Phase
Hematologic Malignancies IND

ZN-e4: EGFR

oral, small molecule inhibitor of mutant epidermal growth factor receptor (EGFR)

Indication Phase
NSCLC 1/2

Top 10 Holders of Zentalis Pharmaceuticals, Inc.

Institution OS (%) Position Mkt Val ($MM) Source Filing Date
Viking Global Investors LP 11.11 4,443,284 130.63 13F 6/30/20
Matrix Capital Management Co. LP 9.55 3,821,739 112.36 13F 6/30/20
Tybourne Capital Management (HK) Ltd. 6.66 2,664,409 78.33 13F 6/30/20
Fidelity Management & Research Co. LLC 5.78 2,310,946 67.94 13F 6/30/20
Citadel Advisors LLC 5.32 2,129,964 62.62 Stakes 4/3/20
Redmile Group LLC 4.15 1,661,205 48.84 13F 6/30/20
Citadel LP 3.90 1,560,687 45.88 13F 6/30/20
T. Rowe Price Associates, Inc. (Investment Management) 2.97 1,187,566 34.91 13F 6/30/20
The Vanguard Group, Inc. 3.14 1,127,302 33.14 Funds 8/31/20
Perceptive Advisors LLC 2.62 1,050,003 30.87 13F 6/30/20
Ownership data is sourced through FactSet.

Stock Market Data

Data is being loaded...
Data is being loaded...
Data is being loaded...
Data is being loaded...
Market Data copyright © 2020 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, RTB=Real-Time BATS BZX Price/Quote; not sourced from all markets, RTN=Real-Time NASDAQ Basic+ Price/Quote; not sourced from all markets, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.